Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | CA12 | O43570 | 2/20 | 0.58 |
| ▸ | CA1 | P00915 | 2/20 | 0.58 |
| ▸ | CA2 | P00918 | 2/20 | 0.58 |
| ▸ | CA7 | P43166 | 2/20 | 0.58 |
| ▸ | CA9 | Q16790 | 2/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.58 |
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | NOS3 | P29474 | 2/20 | 0.54 |
| ▸ | NOS1 | P29475 | 2/20 | 0.54 |
| ▸ | NOS2 | P35228 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7532308 | 0.91 | L3MBTL1 (0.54) | MAPTNPC1RAB9ACA12CA1 | |
| SCHEMBL813539 | 0.86 | TSHR (0.47) | MAPTNPC1RAB9AESR1ESR2 | |
| SCHEMBL8729519 | 0.85 | CYP3A4 (0.52) | MAPTNPC1RAB9ACA12CA1 | |
| SCHEMBL8675817 | 0.85 | L3MBTL1 (0.49) | MAPTNPC1RAB9ACYP1A2CYP3A4 | |
| SCHEMBL24340326 | 0.85 | MAPT (0.56) | MAPTNPC1RAB9ACA12CA1 | |
| SCHEMBL1457515 | 0.85 | MAPT (0.56) | MAPTNPC1RAB9ACA12CA1 | |
| SCHEMBL273609 | 0.84 | ESR1 (0.62) | MAPTNPC1RAB9AESR1LMNA | |
| SCHEMBL9751347 | 0.83 | TDP1 (0.55) | MAPTNPC1RAB9ACA12CA1 | |
| SCHEMBL6891912 | 0.82 | CYP1A2 (0.50) | MAPTNPC1RAB9ACA12CA1 | |
| SCHEMBL3080728 | 0.82 | MAPT (0.75) | MAPTNPC1RAB9ACA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 789 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119789746-A | Solar cell and preparation method thereof | 北京曜能光电科技有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-114014838-B | Compound and preparation method and application thereof | 山东师范大学 | 2024-03-19 | — | — | CN | claimed |
| US-20230151136-A1 | CATALYST COMPOSITION FOR POLYURETHANES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-05-18 | — | — | US | claimed |
| US-20230134280-A1 | CATALYSTS FOR THE FORMATION OF POLYURETHANES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-05-04 | — | — | US | claimed |
| EP-4114877-A1 | CATALYSTS FOR THE FORMATION OF POLYURETHANES | Momentive Performance Materials Inc. (US) | 2023-01-11 | — | — | EP | claimed |
| EP-4114566-A1 | CATALYST COMPOSITION FOR POLYURETHANES | Momentive Performance Materials Inc. (US) | 2023-01-11 | — | — | EP | claimed |
| CN-115386245-A | Preparation method and application of lipophilic carbon nitride nanosheet | 浙江理工大学 | 2022-11-25 | — | — | CN | claimed |
| CN-113956232-B | Quinoline-bisindole compound and preparation method and application thereof | 山东师范大学 | 2022-09-16 | — | — | CN | claimed |
| CN-114957117-A | N-substituted-4- [3- (quinoline-6-yl) ureido ] benzoyl hydrazine derivative and preparation method and application thereof | 浙江师范大学行知学院 | 2022-08-30 | — | — | CN | claimed |
| CN-114014838-A | Compound and preparation method and application thereof | 山东师范大学 | 2022-02-08 | — | — | CN | claimed |
| US-20040215002-A1 | Colorant compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-20040215038-A1 | Colorant precursor compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-20040214918-A1 | Colorant compositions | XEROX CORPORATION | 2004-10-28 | — | — | US | claimed |
| US-6790267-B1 | METHINE COLORANT COMPOUNDS FOR PHASE CHANGE INKS | XEROX CORPORATION | 2004-09-14 | — | — | US | claimed |
| US-20040167249-A1 | Phase change inks with isocyanate-derived antioxidants and UV stabilizers | XEROX CORPORATION | 2004-08-26 | — | — | US | claimed |
| US-6764541-B1 | Colorant compositions | XEROX CORPORATION | 2004-07-20 | — | — | US | claimed |
| US-6652635-B2 | Cyan phase change inks | XEROX CORPORATION | 2003-11-25 | — | — | US | claimed |
| US-20030079645-A1 | Cyan phase change inks | XEROX CORPORATION | 2003-05-01 | — | — | US | claimed |
| EP-0595921-A1 | PREPARATION OF NONLINEAR OPTICAL ELEMENTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-05-11 | — | — | EP | claimed |
| WO-1993002384-A1 | PREPARATION OF NONLINEAR OPTICAL ELEMENTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-02-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040215038-A1 | Colorant precursor compositions | RB1, SULT1A1, CBR1 | MAPT 4304/4885NPC1 1895/4885RAB9A 1804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.